Foreign drug makers fear disgraced corporate image over rebate scandal
Published: 2007-11-14 07:00:00
Updated: 2007-11-14 07:00:00
With the Fair Trade Commission's second announcement of rebate scandal involving several foreign-invested pharmaceutical firms, there are growing concerns that the commission's disclosure will tarnish the reliability and morality of these foreign players throughout the world.
Enforcing a princ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
